Medicure Inc. (OTCMKTS:MCUJF) Short Interest Up ∞ in August

Medicure Inc. (OTCMKTS:MCUJF) saw a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 5,532 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average daily trading volume, of 26,278 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the company are short sold.

Medicure Stock Performance

MCUJF traded down $0.08 during trading on Wednesday, hitting $1.85. The stock had a trading volume of 5,000 shares, compared to its average volume of 8,381. Medicure has a twelve month low of $0.67 and a twelve month high of $1.93. The firm has a market capitalization of $19.31 million, a P/E ratio of -3.63 and a beta of 1.15. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.64 and a current ratio of 0.97. The company’s 50-day moving average price is $1.11 and its 200 day moving average price is $0.91.

Medicure (OTCMKTS:MCUJF) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). The company had revenue of $5.36 million during the quarter, compared to analysts’ expectations of $2.45 million. Medicure had a negative net margin of 23.14% and a negative return on equity of 54.55%.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.